Abbott Laboratories (ABT)

109.91
NYSE
Prev Close 110.15
Day Low/High 109.51 / 110.33
52 Wk Low/High 86.16 / 128.54
Exchange NYSE
Shares Outstanding 1776.82B
Market Cap 195.72B
P/E Ratio 60.02
Div & Yield N.A. (N.A)

Latest News

Abbott Rated New Overweight at Barclays

Best Stocks With DRIP Plans Right Now

Best Stocks With DRIP Plans Right Now

These Dividend Aristocrats have free DRIPs, long histories of raising their dividends, and attractive yields well above the market average.

Key Chart Favors a Nice Rise in Abbott Labs Later This Year

Key Chart Favors a Nice Rise in Abbott Labs Later This Year

The technical signals indicate the odds of further weakness in the health care company's shares are low.

Investors on United Airlines Could See a Bumpy Ride Ahead

Investors on United Airlines Could See a Bumpy Ride Ahead

Consider other 'travel plans.'

New Moon on Monday, Fair Warning on Semis and Small-Caps, Ballad of Nvidia, IBM

New Moon on Monday, Fair Warning on Semis and Small-Caps, Ballad of Nvidia, IBM

Always, always, always stick to your rules. Always. This is why we have targets, pivots and panics.

We've Changed Our Strategy on Abbott Laboratories

We've Changed Our Strategy on Abbott Laboratories

The charts are more mixed now.

Revisiting an S&P 500 Chart Setup and Tracking 2 Stocks on Pullbacks

Revisiting an S&P 500 Chart Setup and Tracking 2 Stocks on Pullbacks

Microsoft and Abbott Laboratories are the names that are worth watching.

Jim Cramer: There's Good Risk and Bad Risk

Jim Cramer: There's Good Risk and Bad Risk

Here's the kind I like to buy -- and the vetted stocks that you can play on 'good' risk.

Here's a Quick Technical Update on Abbott Laboratories

Here's a Quick Technical Update on Abbott Laboratories

Traders should continue to hold existing longs on ABT.

Underperforming Transports, Vaccine Delivery, FOMC Statement, 3 Trading Thoughts

Underperforming Transports, Vaccine Delivery, FOMC Statement, 3 Trading Thoughts

Wednesday afternoon the Fed's Federal Open Market Committee will publish the central bank's first official policy statement of 2021.

Abbott Labs Has the Formula for a Long Trade

Abbott Labs Has the Formula for a Long Trade

ABT has made an upside breakout on the daily Point and Figure chart, and here's how investors can make their next move.

Jim Cramer: You Just Won Powerball, Now What?

Jim Cramer: You Just Won Powerball, Now What?

Remember, you only need to get rich once.

8 Quality Dividend Stocks for Durable Growth and Income

8 Quality Dividend Stocks for Durable Growth and Income

Four experts highlight their favorite dividend stocks for 2021.

Jim Cramer: Misconceptions About Covid-19 and Wagering on Its Longevity

Jim Cramer: Misconceptions About Covid-19 and Wagering on Its Longevity

Maybe we will be better when Covid 2021 comes around. But sustainable? Ha. How about inevitable?

Abbott Laboratories Could Soon Break Out From Its Sideways Pattern

Abbott Laboratories Could Soon Break Out From Its Sideways Pattern

Let's review the charts and indicators.

Jim Cramer: 8 Stocks That Benefit the Most If There's Another Modified Lockdown

Jim Cramer: 8 Stocks That Benefit the Most If There's Another Modified Lockdown

These companies have spent the last six months preparing for a second lockdown betting it will occur.

Jim Cramer: Health Care Stocks, the Election and the Perfect Setup

Jim Cramer: Health Care Stocks, the Election and the Perfect Setup

Right now, the market is furiously trying to price in a Blue Wave, and the health care sector is getting clobbered. But here's how I think things play out.

Does Abbott Labs Still Pass My Test After Earnings?

Does Abbott Labs Still Pass My Test After Earnings?

Diagnostics revenue grew an impressive 38% due to the necessity of Covid-19 testing.

'Inside Day', Electoral Risk, Banking Stocks, Stimulus Immediately Needed

'Inside Day', Electoral Risk, Banking Stocks, Stimulus Immediately Needed

There is a presidential debate on Thursday. The market is being forced to adjust for renewed potential uncertainty.

Jim Cramer: This Is How Stocks Would Fare Under a President Biden

Jim Cramer: This Is How Stocks Would Fare Under a President Biden

I don't pick stocks on politics, but was shocked to see how a majority of our Action Alerts PLUS holdings would perform if Joe Biden wins the White House.

Jim Cramer: Better to Mask and Test Than Wait for Vaccine

Jim Cramer: Better to Mask and Test Than Wait for Vaccine

New rapid tests and the effectiveness of universal mask wearing give hope while we wait on the elusive vaccine.

Jim Cramer: Fly Ahead of the Pack on Boeing

Jim Cramer: Fly Ahead of the Pack on Boeing

People want to wait and see on this beleaguered aviation name, but I don't think you can do that. Here's why.

Jim Cramer: You Heard the Ugly of the Debate. Here's the Good.

Jim Cramer: You Heard the Ugly of the Debate. Here's the Good.

Neither candidate seems to be the enemy of the market -- at least not yet.

Abbott Labs Stock Could Still Slip Lower

Abbott Labs Stock Could Still Slip Lower

Let's review the charts and indicators.

Jim Cramer: Abbott's Rapid Covid-19 Test and My Super Bowl Dreams

Jim Cramer: Abbott's Rapid Covid-19 Test and My Super Bowl Dreams

Abbott Labs can bring back some normalcy to this country -- and the world -- with its BinaxNOW rapid antigen test along with its amazing Navica app.

This Dividend Stock's Got the Right Medicine for Investors

This Dividend Stock's Got the Right Medicine for Investors

AbbVie stock is a rare combination of value, growth, and yield, making it a unique pick in the health care sector.

Abbott Rated New Outperform at Wolfe

Charting the Best Hotels in the Sector

Charting the Best Hotels in the Sector

We grade Choice Hotels, Hilton and Marriott, and check on the opportunities each offers.